4-bromo-N-(3-cyano-1-ethyl-6-nitroindol-2-yl)benzamide;N-(3-cyano-1-ethyl-6-nitroindol-2-yl)-3-nitrobenzamide;(1-ethyl-5-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;(1-ethyl-6-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;1-(1-ethyl-6-methoxyindol-3-yl)-2-methylpropan-1-one;3-(4-methoxyphenyl)-5-nitro-1H-indole
C104H95BrN14O19 — CID 158515605
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-bromo-N-(3-cyano-1-ethyl-6-nitroindol-2-yl)benzamide;N-(3-cyano-1-ethyl-6-nitroindol-2-yl)-3-nitrobenzamide;(1-ethyl-5-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;(1-ethyl-6-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;1-(1-ethyl-6-methoxyindol-3-yl)-2-methylpropan-1-one;3-(4-methoxyphenyl)-5-nitro-1H-indole
4-bromo-N-(3-cyano-1-ethyl-6-nitroindol-2-yl)benzamide;N-(3-cyano-1-ethyl-6-nitroindol-2-yl)-3-nitrobenzamide;(1-ethyl-5-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;(1-ethyl-6-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;1-(1-ethyl-6-methoxyindol-3-yl)-2-methylpropan-1-one;3-(4-methoxyphenyl)-5-nitro-1H-indole (PubChem CID 158515605) has the molecular formula C104H95BrN14O19 and a molecular weight of 1924.89 g/mol. Its IUPAC name is 4-bromo-N-(3-cyano-1-ethyl-6-nitroindol-2-yl)benzamide;N-(3-cyano-1-ethyl-6-nitroindol-2-yl)-3-nitrobenzamide;(1-ethyl-5-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;(1-ethyl-6-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;1-(1-ethyl-6-methoxyindol-3-yl)-2-methylpropan-1-one;3-(4-methoxyphenyl)-5-nitro-1H-indole.
Molecular Properties
| Compound Name | 4-bromo-N-(3-cyano-1-ethyl-6-nitroindol-2-yl)benzamide;N-(3-cyano-1-ethyl-6-nitroindol-2-yl)-3-nitrobenzamide;(1-ethyl-5-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;(1-ethyl-6-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;1-(1-ethyl-6-methoxyindol-3-yl)-2-methylpropan-1-one;3-(4-methoxyphenyl)-5-nitro-1H-indole |
|---|---|
| PubChem CID | 158515605 |
| Molecular Formula | C104H95BrN14O19 |
| Molecular Weight | 1924.89 g/mol |
| Exact Mass | 1922.61 |
| IUPAC Name | 4-bromo-N-(3-cyano-1-ethyl-6-nitroindol-2-yl)benzamide;N-(3-cyano-1-ethyl-6-nitroindol-2-yl)-3-nitrobenzamide;(1-ethyl-5-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;(1-ethyl-6-methoxyindol-3-yl)-(3-methoxyphenyl)methanone;1-(1-ethyl-6-methoxyindol-3-yl)-2-methylpropan-1-one;3-(4-methoxyphenyl)-5-nitro-1H-indole |
| SMILES | CCn1c(NC(=O)c2ccc(Br)cc2)c(C#N)c2ccc([N+](=O)[O-])cc21.CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)c(C#N)c2ccc([N+](=O)[O-])cc21.CCn1cc(C(=O)C(C)C)c2ccc(OC)cc21.CCn1cc(C(=O)c2cccc(OC)c2)c2cc(OC)ccc21.CCn1cc(C(=O)c2cccc(OC)c2)c2ccc(OC)cc21.COc1ccc(-c2c[nH]c3ccc([N+](=O)[O-])cc23)cc1 |
| InChI | InChI=1S/2C19H19NO3.C18H13BrN4O3.C18H13N5O5.C15H12N2O3.C15H19NO2/c1-4-20-12-17(16-11-15(23-3)8-9-18(16)20)19(21)13-6-5-7-14(10-13)22-2;1-4-20-12-17(16-9-8-15(23-3)11-18(16)20)19(21)13-6-5-7-14(10-13)22-2;1-2-22-16-9-13(23(25)26)7-8-14(16)15(10-20)17(22)21-18(24)11-3-5-12(19)6-4-11;1-2-21-16-9-13(23(27)28)6-7-14(16)15(10-19)17(21)20-18(24)11-4-3-5-12(8-11)22(25)26;1-20-12-5-2-10(3-6-12)14-9-16-15-7-4-11(17(18)19)8-13(14)15;1-5-16-9-13(15(17)10(2)3)12-7-6-11(18-4)8-14(12)16/h2*5-12H,4H2,1-3H3;3-9H,2H2,1H3,(H,21,24);3-9H,2H2,1H3,(H,20,24);2-9,16H,1H3;6-10H,5H2,1-4H3 |
| InChIKey | SSZCVVUXPLDPDE-UHFFFAOYSA-N |
| XLogP | 23.14 |
| TPSA | 425.37 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 138 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1924.89 |
| LogP ≤ 5 | 23.14 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 26 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158515605 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.